KR20220049619A - 유전자 발현 조절 시스템 - Google Patents

유전자 발현 조절 시스템 Download PDF

Info

Publication number
KR20220049619A
KR20220049619A KR1020227010164A KR20227010164A KR20220049619A KR 20220049619 A KR20220049619 A KR 20220049619A KR 1020227010164 A KR1020227010164 A KR 1020227010164A KR 20227010164 A KR20227010164 A KR 20227010164A KR 20220049619 A KR20220049619 A KR 20220049619A
Authority
KR
South Korea
Prior art keywords
artificial sequence
rna
description
polya
synthetic oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227010164A
Other languages
English (en)
Korean (ko)
Inventor
라이싱 옌
리밍 뤄
조셀린 뒌-야 제아
조셀린 Š‰-야 제아
Original Assignee
베이롤 칼리지 오브 메드신
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베이롤 칼리지 오브 메드신 filed Critical 베이롤 칼리지 오브 메드신
Publication of KR20220049619A publication Critical patent/KR20220049619A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020227010164A 2019-08-30 2020-08-28 유전자 발현 조절 시스템 Pending KR20220049619A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962894611P 2019-08-30 2019-08-30
US62/894,611 2019-08-30
US201962904635P 2019-09-23 2019-09-23
US62/904,635 2019-09-23
US202063043504P 2020-06-24 2020-06-24
US63/043,504 2020-06-24
PCT/US2020/048561 WO2021041924A2 (en) 2019-08-30 2020-08-28 System for regulating gene expression

Publications (1)

Publication Number Publication Date
KR20220049619A true KR20220049619A (ko) 2022-04-21

Family

ID=74683442

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227010164A Pending KR20220049619A (ko) 2019-08-30 2020-08-28 유전자 발현 조절 시스템

Country Status (11)

Country Link
US (1) US20220290147A1 (https=)
EP (1) EP4022065A4 (https=)
JP (2) JP7737152B2 (https=)
KR (1) KR20220049619A (https=)
CN (1) CN115279902A (https=)
AU (1) AU2020335909A1 (https=)
BR (1) BR112022003512A2 (https=)
CA (1) CA3152513A1 (https=)
IL (1) IL290944A (https=)
MX (1) MX2022002390A (https=)
WO (1) WO2021041924A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102904879B1 (ko) 2015-11-12 2025-12-30 베이롤 칼리지 오브 메드신 폴리아데닐화의 압타머 매개된 조정을 통한 포유류 유전자 발현의 외인성 제어
AU2022327174A1 (en) 2021-08-11 2024-02-15 Sana Biotechnology, Inc. Inducible systems for altering gene expression in hypoimmunogenic cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
CA2559280A1 (en) 2004-03-15 2005-09-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
WO2005106035A2 (en) * 2004-04-09 2005-11-10 Cornell Research Foundation, Inc. Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, rna scaffolds, their expression, and methods of use
WO2005116204A1 (ja) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Ｒｎａ干渉を生じさせるポリヌクレオチド、および、これを用いた遺伝子発現抑制方法
US7825229B2 (en) * 2005-03-25 2010-11-02 Rosetta Genomics Ltd. Lung cancer-related nucleic acids
US8178503B2 (en) * 2006-03-03 2012-05-15 International Business Machines Corporation Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
US20150284738A1 (en) * 2006-12-29 2015-10-08 Rodina Holding S.A. Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants
CN103108952A (zh) * 2010-09-01 2013-05-15 日本电气株式会社 检测目标物质的方法以及用于所述方法中的适体组、传感器和装置
EP2622084A1 (en) * 2010-10-01 2013-08-07 R1 B3 Holding B.V. Regulation of translation of expressed genes
WO2013119371A2 (en) * 2012-02-10 2013-08-15 The Board Of Trustees Of The Leland Stanford Junior University Mini-intronic plasmid vectors
US20150141320A1 (en) * 2012-05-16 2015-05-21 Rana Therapeutics, Inc. Compositions and methods for modulating gene expression
US9567581B2 (en) * 2012-08-07 2017-02-14 The General Hospital Corporation Selective reactivation of genes on the inactive X chromosome
KR102699584B1 (ko) 2015-02-02 2024-08-28 메이라지티엑스 유케이 Ii 리미티드 대안적 스플라이싱의 압타머 매개 조절에 의한 유전자 발현 제어
EP3268481B1 (en) * 2015-03-11 2020-05-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Rpgr vectors for treating x-linked retinitis pigmentosa
KR102904879B1 (ko) * 2015-11-12 2025-12-30 베이롤 칼리지 오브 메드신 폴리아데닐화의 압타머 매개된 조정을 통한 포유류 유전자 발현의 외인성 제어

Also Published As

Publication number Publication date
AU2020335909A1 (en) 2022-04-14
US20220290147A1 (en) 2022-09-15
IL290944A (en) 2022-04-01
WO2021041924A2 (en) 2021-03-04
MX2022002390A (es) 2022-05-13
JP2025118711A (ja) 2025-08-13
JP2022546408A (ja) 2022-11-04
CN115279902A (zh) 2022-11-01
BR112022003512A2 (pt) 2022-05-17
EP4022065A2 (en) 2022-07-06
JP7737152B2 (ja) 2025-09-10
WO2021041924A3 (en) 2021-04-08
EP4022065A4 (en) 2024-02-14
CA3152513A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
AU2019280583B2 (en) Circular RNA for translation in eukaryotic cells
JP2024536853A (ja) 環状ｒｎａおよびその調製方法
KR20210135265A (ko) 원형 폴리리보뉴클레오티드 및 그의 약제학적 조성물
KR20230002401A (ko) C9orf72의 표적화를 위한 조성물 및 방법
CN112513250A (zh) 用于跟踪和操纵细胞rna的融合蛋白和融合核糖核酸
CN114174520A (zh) 用于选择性基因调节的组合物和方法
CN107522787A (zh) 在细胞内产生点突变的融合蛋白、其制备及用途
CN105960413A (zh) 人工dna-结合蛋白及其用途
JP6956416B2 (ja) トランスポゾン系、それを含むキット及びそれらの使用
KR102876612B1 (ko) 하나 이상의 비-고유 꼬리 섬유를 가지는 비-복제성 형질도입 입자 및 형질도입 입자-기반 리포터 시스템
KR20230129162A (ko) 제1형 근긴장성 이영양증을 치료하기 위한 rna 표적화조성물 및 방법
CN117015605A (zh) 使用工程化rna通过利用内源性adar进行靶向rna编辑
WO2022167009A1 (zh) 靶向Aqp1 mRNA的sgRNA及其载体与应用
CN116783295A (zh) 指导rna的新型设计及其用途
CN118291452B (zh) 一种基于i型内含子核酶体外制备环状rna的系统及其应用
KR20250153190A (ko) 환형 리보핵산을 합성하기 위한 조성물 및 방법
JP2025118711A (ja) 遺伝子発現を調節するためのシステム
WO2024238321A1 (en) Compositions and methods for targeted epigenetic modification
CN101313067B (zh) 以rna干扰特异性抑制基因表达的dna构建体
JPWO2018139637A1 (ja) 核酸封入ａａｖ中空粒子
CN118480526A (zh) 一种转座酶、转座子、转座子系统及其应用
CN118652889B (zh) 一种环状核酶系统及其应用
US20250002946A1 (en) Methods And Compositions For Increasing Homology-Directed Repair
WO2021048366A1 (en) Method for the production of raav and method for the in vitro generation of genetically engineered, linear, single-stranded nucleic acid fragments containing itr sequences flanking a gene of interest
WO2024040202A1 (en) Fusion proteins and uses thereof for precision editing

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000